(Q40298440)

English

Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations

scientific article published on 14 August 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Different doses of amodiaquine and chloroquine for treatment of uncomplicated malaria in children in Guinea-Bissau: implications for future treatment recommendations (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

(RS)-chloroquine

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

Johan Ursing

2

0 references

object named as

Peter Aaby

6

0 references

Amabélia Rodrigues

4

object named as

Amabelia Rodrigues

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Poul-Erik Kofoed

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Anja Poulsen

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yngve Bergquist

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lars Rombo

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

14 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

231-238

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Artesunate combinations for treatment of malaria: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Should chloroquine be laid to rest?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

No benefits from combining chloroquine with artesunate for three days for treatment of Plasmodium falciparum in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Systematic review of amodiaquine treatment in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Randomized comparison of chloroquine and amodiaquine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Antimalarial Drug Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.05.008

7 January 2021

Identifiers

10.1016/J.TRSTMH.2006.05.008

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40298440&oldid=1894189596"